Skip to content

Biomimetic Hydroxyapatite in Pediatric Patients With Asthma and/or Allergic Rhinitis

Biomimetic Hydroxyapatite vs Fluoride for the Domiciliary Oral Hygiene of Pediatric Patients With Asthma and/or Allergic Rhinitis: Randomized Clinical Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05631197
Enrollment
40
Registered
2022-11-30
Start date
2022-03-02
Completion date
2023-09-30
Last updated
2023-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries, Periodontal Diseases

Keywords

Dental hygiene

Brief summary

The aim of the study is to compare the incidence of dental caries and the level of demineralization in pediatric patients with asthma and/or allergic rhinitis. Patients will conduct professional oral hygiene at the baseline. The following clinical indexes will be assessed: BEWE Index, Plaque Index, Bleeding Score, Schiff Air Index. Then, patients will be randomly divided into two groups: * Trial group: domiciliary use of Biorepair Total Protection Plus + desensitizing enamel-repair shock treatment twice a day * Control group: domiciliary use of Elmex Caries Protection twice a day The clinical indexes will be assessed again after 1 month (T1), after 3 (T2) and 6 months (T3).

Interventions

OTHERBiorepair Total Protection Plus + desensitizing enamel-repair shock treatment

Domiciliary use twice a day

Domiciliary use twice a day

Sponsors

University of Pavia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
6 Years to 14 Years
Healthy volunteers
No

Inclusion criteria

* pediatric patients aged between 6-14 years * diagnosis of allergic rhinitis and asthma * therapy with salmeterol/fluticasone propionate * diffused enamel demineralizations of deciduous and permanent teeth

Exclusion criteria

* low cooperation according to grades 3 and 4 of Frankl behavioral scale * nonadherence to the study protocol checked by parents * other systemic diseases.

Design outcomes

Primary

MeasureTime frameDescription
Change in Shiff Air Index - Dental sensitivity testBaseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Scoring criteria: 0 = the subject did not respond to air blasting; 1. = the subject responded to air blasting; 2. = the subject responded to air blasting and requested discontinuation; 3. = the subject responded to air blasting, requested discontinuation and considered the stimulus to be painful.
Change of the BEWE Index - Basic Erosive Wear Examination (Barlet et al.2008)Baseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Scoring criteria: 0 = no erosive tooth wear; 1. = initial loss of surface texture; 2. = distinct defect, hard tissue loss \< 50% of the surface area; 3. = hard tissue loss ≥ 50% of the surface area. The BEWE will be assessed with Intact Tooth application
Change in BoP - Bleeding on ProbingBaseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Scoring criteria: Percentage of bleeding sites (mesial, distal, vestibular, lingual) of each teeth on the total available sites.
Change in PI - Plaque Index (Silness and Löe, 1964)Baseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Scoring criteria: 0 = no plaque; 1. = thin plaque layer at the gingival margin, only detectable by scraping with a probe; 2. = moderate layer of plaque along the gingival margin; interdental spaces free, but plaque is visible to the naked eye; 3. = abundant plaque along the gingival margin; interdental spaces filled with plaque.
Change in salivary pHBaseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Use of Just Fitter strips to assess salivary pH.
Change in SI - Susceptibility IndexBaseline (T0), 1 month (T1), 3 months (T2), 6 months (T3)Scoring criteria: * mild: 6.7\< pH \<7.8, BEWE 0-1, SAI 0-1 * moderate: 6.0 \<pH \<6.6, BEWE 1-2, SAI 1-2 * severe: pH \<6.6, BEWE 2-3, SAI 2-3

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026